- Home
- HOTH vs BFRG Comparison
HOTH vs BFRG Comparison
Compare HOTH & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- BFRG
- Stock Information
- Founded
- HOTH 2017
- BFRG 2017
- Country
- HOTH United States
- BFRG United States
- Employees
- HOTH N/A
- BFRG N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- HOTH Health Care
- BFRG Technology
- Exchange
- HOTH Nasdaq
- BFRG Nasdaq
- Market Cap
- HOTH 15.6M
- BFRG 16.4M
- IPO Year
- HOTH 2019
- BFRG 2023
- Fundamental
- Price
- HOTH $1.29
- BFRG $1.27
- Analyst Decision
- HOTH Strong Buy
- BFRG
- Analyst Count
- HOTH 3
- BFRG 0
- Target Price
- HOTH $4.00
- BFRG N/A
- AVG Volume (30 Days)
- HOTH 230.9K
- BFRG 116.0K
- Earning Date
- HOTH 08-12-2025
- BFRG 08-13-2025
- Dividend Yield
- HOTH N/A
- BFRG N/A
- EPS Growth
- HOTH N/A
- BFRG N/A
- EPS
- HOTH N/A
- BFRG N/A
- Revenue
- HOTH N/A
- BFRG $33,257.00
- Revenue This Year
- HOTH N/A
- BFRG N/A
- Revenue Next Year
- HOTH N/A
- BFRG N/A
- P/E Ratio
- HOTH N/A
- BFRG N/A
- Revenue Growth
- HOTH N/A
- BFRG N/A
- 52 Week Low
- HOTH $0.65
- BFRG $1.17
- 52 Week High
- HOTH $3.80
- BFRG $4.84
- Technical
- Relative Strength Index (RSI)
- HOTH 50.80
- BFRG 42.25
- Support Level
- HOTH $1.22
- BFRG $1.17
- Resistance Level
- HOTH $1.31
- BFRG $1.33
- Average True Range (ATR)
- HOTH 0.08
- BFRG 0.07
- MACD
- HOTH -0.00
- BFRG 0.00
- Stochastic Oscillator
- HOTH 57.69
- BFRG 46.67
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.